败血症引起的急性肺损伤中的循环RNA:新出现的机制和治疗潜力
Qinghai Liu1, Yiyan Wang1, Haitang Liao1
1Department of Critical and Emergency Medicine, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
Frontiers in immunology
|March 6, 2026
概括
循环RNAs (circRNAs) 是败血症引起的急性肺损伤 (ALI) 的关键调节者. 本综述总结了它们在炎症和屏障功能障碍中的作用,强调了它们作为ALI生物标志物和治疗点的潜力.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 关键护理医学 关键护理医学
背景情况:
- 败血症引起的急性肺损伤 (ALI) 是重症患者的主要死亡原因.
- ALI涉及炎症,免疫失衡和屏障功能障碍.
- 循环RNAs (circRNAs) 越来越多地被认为在炎症性疾病中的作用.
研究的目的:
- 为了提供一个全面的概述circRNA功能在败血症相关的肺损伤.
- 探索circRNAs作为潜在的诊断生物标记物和ALI的治疗点.
- 为应对circRNA研究和临床翻译当前的挑战.
主要方法:
- 文献综述和现有研究的综合研究circRNAs在败血症诱导的ALI.
- 对circRNA生物发生,分类和调控机制的分析.
- 讨论在败血症肺部上下文依赖的circRNA功能.
主要成果:
- 在败血症期间,circRNAs在调节细胞命运,免疫反应和膜-毛囊屏障完整性方面发挥着至关重要的作用.
- 特定的circRNAs涉及到败血症诱导的ALI的发病.
- 循环RNAs作为诊断生物标志物和ALI的治疗标显示出希望.
结论:
- 循环RNAs是败血症诱导的ALI的重要参与者,影响关键的病理过程.
- 需要进一步的研究来克服临床应用的技术和翻译挑战.
- 了解circRNA机制为治疗败血症引起的肺损伤提供了新的途径.
相关概念视频
01:21Acute Respiratory Failure-II
1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
01:29Acute Respiratory Failure-V
564
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
564
01:21Acute Respiratory Failure-I
1.3K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.3K
01:30Acute Respiratory Failure-III
1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
01:29Pneumonia II: Pathophysiology
3.7K
The pathophysiology of pneumonia involves the following steps:
3.7K